Corrigendum to “Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects” [Pharmacol. Res. 60 (2009) 159–169]
Clara De Palma,
Rosanna Di Paola,
Cristiana Perrotta,
Emanuela Mazzon,
Dario Cattaneo,
Emilio Trabucchi,
Salvatore Cuzzocrea,
Emilio Clementi
Affiliations
Clara De Palma
Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milano, 20157 Milan, Italy
Rosanna Di Paola
IRCCS Centro Neurolesi “Bonino-Pulejo”, Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, 98100 Messina, Italy
Cristiana Perrotta
Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milano, 20157 Milan, Italy
Emanuela Mazzon
IRCCS Centro Neurolesi “Bonino-Pulejo”, Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, 98100 Messina, Italy
Dario Cattaneo
ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, 20157 Milan, Italy
Emilio Trabucchi
Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milano, 20157 Milan, Italy
Salvatore Cuzzocrea
IRCCS Centro Neurolesi “Bonino-Pulejo”, Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, 98100 Messina, Italy
Emilio Clementi
Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milano, 20157 Milan, Italy; E. Medea Scientific Institute, 23842 Bosisio Parini, Lecco, Italy; Corresponding author at: Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milano, 20157 Milan, Italy.
